The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma. (Q27852466)
Jump to navigation
Jump to search
scientific article
- The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma
Language | Label | Description | Also known as |
---|---|---|---|
English | The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma. |
scientific article |
|
Statements
The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma (English)
Toni K Choueiri
André P Fay
Robert Gagnon
Ying Lin
Brittany Bahamon
Victoria Brown
Thomas E Hutson
Katherine L Baker-Neblett
Christopher Carpenter
Yuan Liu
1 reference
1 reference
1 reference
Identifiers
2 references
2 references
2 references